Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma
Open Access
- 29 November 2010
- journal article
- review article
- Published by Hindawi Limited in Advances in Hematology
- Vol. 2011, 1-10
- https://doi.org/10.1155/2011/736261
Abstract
Epidemiological studies suggest unique occurrence patterns of Hodgkin lymphoma (HL) worldwide. In most Western countries there is a clear bimodal age distribution with an early peak in young adults followed by a second peak in older adults, particularly among males. In the Middle East and Asia, HL is more common in early childhood. There also are marked racial differences in the presentations of HL and HL subtypes, and particular single nucleotide polymorphisms (SNPs) have been identified as etiological factors suggesting that gene-gene and gene-environment interactions are involved. Personal health choices such as exercise and smoking may modify an individual's chances of developing HL. Numerous studies highlight the impact that exposure to Epstein-Barr virus and other environmental factors have on HL risk. Understanding the relative importance of each of these findings and their links to HL development and survival will help clinical researchers expand curative therapies and create preventative strategies for HL.Keywords
This publication has 57 references indexed in Scilit:
- Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United StatesAdvances in Hematology, 2010
- HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphomaProceedings of the National Academy of Sciences of the United States of America, 2010
- Aspirin and Other Nonsteroidal Anti-inflammatory Drugs in Relation to Hodgkin Lymphoma Risk in Northern DenmarkCancer Epidemiology, Biomarkers & Prevention, 2010
- A protective role for early oral exposures in the etiology of young adult Hodgkin lymphomaBlood, 2009
- Ethnicity and incidence of Hodgkin lymphoma in Canadian populationBMC Cancer, 2009
- TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaThe Journal of Experimental Medicine, 2009
- Polymorphic Variation in NFKB1 and Other Aspirin-Related Genes and Risk of Hodgkin LymphomaCancer Epidemiology, Biomarkers & Prevention, 2009
- Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survivalBlood, 2007
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSBlood, 2006
- Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's LymphomaThe American Journal of Pathology, 2006